Can PRP Injections Regrow Knee Cartilage? New MRI Evidence for High-Dose PRP
- 1 hour ago
- 7 min read
By Dr. Jeffrey Peng, MD · Published April 3, 2026 · 8 min read
Watch the Full Video
There is now MRI evidence that platelet-rich plasma (PRP) injections can help facilitate the regrowth of knee cartilage. A 42-year-old physically active male developed a progressive osteochondral defect after snowboarding. He tried rehabilitation, corticosteroid injections, and even standard PRP — none of which resolved his condition. His orthopedic surgeon recommended arthroscopic surgery. Instead, the patient opted for a series of high-concentration PRP injections combined with hyaluronic acid. His follow-up MRI showed the defect had begun to heal, with new cartilage tissue filling in where a full-thickness defect had previously existed.
This case — the second published report of MRI-confirmed cartilage healing with PRP — adds to a growing body of evidence that high-dose PRP protocols may offer meaningful cartilage protection and even partial structural restoration. In this article, I break down the case, explain what made this PRP protocol different, and review the clinical evidence supporting high-dose PRP for knee osteoarthritis and cartilage injuries.
What Is an Osteochondral Defect?
An osteochondral defect is an area of damage that extends through the articular cartilage into the underlying subchondral bone. Unlike isolated cartilage softening or surface-level wear, these lesions involve both the cartilage layer and the bone beneath it. They can result from acute trauma, repetitive microtrauma, or progressive degeneration. Symptoms typically include persistent joint pain, swelling, mechanical catching, and functional limitation. Traditional management ranges from physical therapy and anti-inflammatory medications to surgical interventions such as arthroscopic microfracture or osteochondral autograft transfer.
When Standard Treatments Fail: One Patient's Journey
The patient in this case was a 42-year-old physically active male who developed persistent right knee pain following a snowboarding session in November 2023. There was no direct trauma — no fall or collision — only repetitive jumping. Over the subsequent weeks, he experienced progressive pain, weakness, and an inability to climb stairs, run, or jump. Walking and cycling pain was rated 5 out of 10, while running and jumping reached 9 out of 10 (Mubark, 2026).
His initial MRI in March 2024 revealed partial-thickness cartilage loss, chondral delamination of the trochlear groove, synovitis, and grade 3 fissuring of the posterior lateral tibial plateau cartilage. Despite physical therapy, acupuncture, and cupping, his symptoms persisted. A corticosteroid injection in August 2024 provided minimal relief. When imaging was repeated in October 2024, the damage had worsened — a large osteochondral defect was now visible in the lateral tibial area, accompanied by full-thickness cartilage degeneration in the lateral tibiofemoral compartment (Mubark, 2026).
At that point, he received a low-dose PRP injection prepared from approximately 15 to 30 mL of blood. A follow-up MRI in March 2025 showed a mild reduction in the size of the osteochondral defect — an encouraging imaging finding — but his symptoms remained unchanged. He was referred to an orthopedic surgeon, who recommended arthroscopic microfracture. The patient sought a second opinion instead.
How High-Concentration PRP Changed the Outcome
The patient ultimately received a series of high-dose PRP injections combined with hyaluronic acid. For each session, 50 mL of autologous blood was drawn — roughly two to three times the volume used in standard PRP preparations — yielding an estimated 8 billion platelets per injection. The blood was processed into a high-concentration, leukocyte-poor formulation and then combined with soluble hyaluronic acid before injection (Mubark, 2026).
Hyaluronic acid serves a dual purpose in this protocol. It restores viscoelasticity within the joint and may help retain the growth factors released by platelets in the joint space for a longer period, allowing more sustained interaction with damaged tissue. Each injection was performed intra-articularly under ultrasound guidance using sterile technique with ropivacaine for local anesthesia. The patient received three treatment sessions over four months — in June, September, and October 2025. Throughout this period, he continued a structured rehabilitation program including quadriceps strengthening, proprioception training, and progressive loading.
What Did the Follow-Up MRI Show?
Following treatment, the patient reported progressive relief of both lateral and anterior knee pain, improved quadriceps strength, and enhanced knee stability. His pain scores improved substantially: walking and cycling went from 5 out of 10 to zero, running and jumping dropped from 9 to 4, and stair climbing went from 8 to 4. He also regained full range of motion and flexion of the knee (Mubark, 2026).
The most significant finding, however, was on the follow-up MRI. The tibial osteochondral defect — the same lesion that had been progressively worsening on every prior scan and had prompted a surgical recommendation — showed interval healing. Moreover, the MRI demonstrated early lateral cartilage infilling, meaning new cartilage tissue was beginning to fill in where a full-thickness defect had previously existed. This is a patient whose cartilage damage worsened despite rehabilitation, worsened despite corticosteroids, and did not meaningfully improve with low-dose PRP. After three sessions of high-concentration PRP with hyaluronic acid over four months, he achieved both symptomatic improvement and structural evidence of healing on MRI.
Is This the First Time PRP Has Healed Cartilage on MRI?
This is not the first published case of MRI-confirmed cartilage healing with PRP. In 2023, a case report described what is believed to be the first such finding. The patient was a 37-year-old active male with a chronic osteochondral defect of the medial femoral condyle measuring 2.2 by 1.4 centimeters. After four high-dose PRP injections over three years, follow-up MRI showed the defect had reduced to 0.7 by 0.5 centimeters (Baria et al., 2023).
The case discussed in this article is now the second — and it goes a step further by demonstrating not only bone healing but also early cartilage infilling on MRI. Two published cases, two different patients, two different countries, both showing MRI-confirmed structural healing after serial high-dose PRP. These findings align with a much larger body of evidence demonstrating that PRP has cartilage-protective properties.
Does PRP Protect Cartilage Long Term?
Beyond individual case reports, a growing body of clinical research supports the cartilage-protective effects of PRP. A 2025 study by Sekiya and colleagues used a precise 3D-MRI analysis system to measure cartilage thickness before and six months after a single PRP injection in 21 knees with medial knee osteoarthritis. In certain regions — particularly the anteromedial femoral cartilage — up to 43 percent of patients showed measurable increases in cartilage thickness. Any increase in cartilage thickness in a degenerative joint following a single injection is a noteworthy finding (Sekiya et al., 2025).
The longer-term data is equally compelling. In one of the most rigorous randomized controlled trials to date — a double-blind, multi-center, sham-controlled study of over 600 patients followed for five years — the group that received high-dose PRP from a 50 mL blood draw lost roughly 50 percent less cartilage volume compared to the saline group over 60 months. That represents measurable structural protection of the joint over a five-year period (Chu et al., 2022).
Does Platelet Dose Matter for PRP Results?
A 2025 systematic review addressed this question directly, finding that higher platelet doses are consistently associated with better clinical outcomes for knee osteoarthritis. The review identified an absolute platelet count of approximately 10 billion as an important threshold for sustained cartilage protection at one year (Berrigan et al., 2025). This aligns directly with the cases discussed above — both used high-volume blood draws to achieve high platelet concentrations, and both demonstrated structural improvements on imaging that were not seen with lower-dose protocols.
In my practice, this is one of the reasons I emphasize that not all PRP is the same. The preparation method, platelet concentration, leukocyte content, and injection volume all influence outcomes. Patients considering PRP therapy should ask their provider about the specific protocol being used, including the blood draw volume and estimated platelet yield.
What Does This Mean for Patients Considering PRP?
These are case reports — two patients, not two hundred. Randomized controlled trials are needed to confirm whether high-concentration PRP can reliably produce cartilage regeneration. However, combined with the broader evidence showing that PRP slows cartilage loss and reduces joint inflammation, the trajectory is promising — especially when high-dose protocols are used.
If you are dealing with knee pain, cartilage damage, or an osteochondral defect and want to explore whether PRP may be appropriate for your situation, I encourage you to schedule a consultation to discuss your options. The key questions to ask include what type of PRP preparation is being used, what platelet concentration it achieves, and whether your provider uses imaging guidance for the injection.
References
1. Mubark H. Serial High-Concentration Platelet-Rich Plasma for Resolution of Tibial Osteochondral Defect and Partial Cartilage Healing: A Case Report. J Med Clin Res Rev. 2026;10(3):1-4. Full Text
2. Baria MR, Barnes R, Flanigan D, Kaeding C. Platelet-rich plasma induced healing of a chronic osteochondral defect of the knee. J Cartilage Joint Preservation. 2023;3(4):100132. doi:10.1016/j.jcjp.2023.100132
3. Sekiya I, Katano H, Mizuno M, et al. 3D-MRI analysis of cartilage thickness changes after PRP injection in medial knee osteoarthritis: A preliminary report. PLoS One. 2025;20(4):e0321067. doi:10.1371/journal.pone.0321067
4. Chu J, Duan W, Yu Z, et al. Intra-articular injections of platelet-rich plasma decrease pain and improve functional outcomes than sham saline in patients with knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2022;30(12):4063-4071. doi:10.1007/s00167-022-06887-7
5. Berrigan WA, Bailowitz Z, Park A, Reddy A, Liu R, Lansdown D. A Greater Platelet Dose May Yield Better Clinical Outcomes for Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review. Arthroscopy. 2025;41:809-817.e2. doi:10.1016/j.arthro.2024.03.018
Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.
Comments